SCHEMBL30123979

SCHEMBL30123979

Oc1c(Br)cccc1-c1cc(N2CCNCC2)no1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.42
SLC6A3 Q01959 2/20 0.42
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
HTR3E A5X5Y0 2/20 0.37
HTR3B O95264 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HTR3A P46098 2/20 0.37
HTR3D Q70Z44 2/20 0.37
HTR3C Q8WXA8 2/20 0.37
ADRB1 P08588 2/20 0.36
CYP1A2 P05177 3/20 0.36
PLD1 Q13393 1/20 0.35
SMARCA2 P51531 1/20 0.35
SMARCA4 P51532 1/20 0.35
PBRM1 Q86U86 1/20 0.35
SCD O00767 1/20 0.34
KDM4E B2RXH2 2/20 0.34
CYP2C19 P33261 1/20 0.34
HTR6 P50406 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24719517 1.00 SLC6A2 (0.42) SLC6A2SLC6A3HSP90AA1HSP90AB1HTR3E
Bromide SCHEMBL29182849 0.99 SLC6A2 (0.41) SLC6A2SLC6A3HSP90AA1HSP90AB1HTR3E
SCHEMBL30931122 0.80 HTR7 (0.44) SLC6A2SLC6A3HTR3ASCDHTR6
SCHEMBL30931000 0.76 HTR7 (0.51) SLC6A2SLC6A3HSP90AA1HSP90AB1HTR3E
SCHEMBL30124547 0.76 SMARCA2 (0.46) ALDH1A1SMARCA2SMARCA4PBRM1
SCHEMBL29182705 0.76 SMARCA2 (0.46) ALDH1A1SMARCA2SMARCA4PBRM1
SCHEMBL24719664 0.75 MAPKAPK2 (0.45)
SCHEMBL30124692 0.75 MAPKAPK2 (0.45)
SCHEMBL24720721 0.75 RPS6KA3 (0.37) SLC6A2SLC6A3ALDH1A1HTR7
SCHEMBL24719652 0.74 MAPKAPK2 (0.38) SLC6A2SLC6A3HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4351560-A1 ANTICANCER COMPOUNDS The Regents of the University of California (US) 2024-04-17 EP disclosed
CN-117794525-A Anticancer compounds 加利福尼亚大学董事会 2024-03-29 CN disclosed
WO-2022261204-A1 ANTICANCER COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-12-15 WO disclosed